Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort

European Journal of Nuclear Medicine and Molecular Imaging · Published 2026-07-07 · DOI 10.1007/s00259-026-08037-4

Authors (13)

Muammer Misirci, Florian Rosar, Fadi Khreish, Caroline Burgard, Arne Blickle, Mark Bartholomä, Stephan Maus, Moritz B. Bastian, Tilman Speicher, Sven Petto, Sebastian Ganz, Andrea Schaefer-Schuler, Samer Ezziddin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Misirci, M., Rosar, F., Khreish, F., et al. (2026). Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08037-4

Related articles

• Whole-body TSPO-PET reveals stage-dependent disruption of systemic immune organ interactions in glioblastoma · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• Evaluation of treatment efficacy of the 161Tb- and 177Lu-Labeled GRPR antagonists AMTG and RM2 in a mouse model of prostate cancer · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• From image reconstruction to clinical prognosis: A comprehensive analysis of centiloid-based amyloid PET assessment · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• [18F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• CSF proteomic pathway alterations and caudate dopamine transporter deficits predict cognitive vulnerability in early Parkinson’s disease · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• Skeletal muscle radiodensity as an automated survival predictor in men with metastatic castration-resistant prostate cancer undergoing PSMA-targeted radioligand therapy · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• In vivo multimodal PET/MRI imaging and plasma biomarkers implicate glymphatic dysfunction linking neuroinflammation to tau pathology in the early Alzheimer’s disease continuum · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• Prospective comparison of [68Ga]Ga-FAPI-04 PET/MRI, [18F]FDG PET/CT, and contrast-enhanced MRI for predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• 68Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal
• Personalized metabolic connectome analysis reveals glucose heterogeneity in ischemic cerebrovascular disease · European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Same journal